Vaxart's (NASDAQ: VXRT) shares rose following the positive results from an early-stage trial of its new oral pill vaccine for norovirus, a more advanced version compared to its first-generation ...

Data from the Healthy Minds Study reveals that the percentage of students considering self-injury has not increased the past two years, after more than doubling from 14% in 2007 to 29% in 2022.

Every Positive And Negative Scale-Bearing Merchant Deal In Nightreign You can fight this mysterious merchant, or maybe it's better to take it up on an offer you can't refuse Elden Ring By George Yang ...

S&P 500 futures: Extending advances above 6,000 This morning, the S&P 500 futures contract is extending its short-term uptrend, breaking above the 6,050 level after the CPI data.

Currently, the candidate is not approved by regulatory authorities anywhere in the world. The company also expects to report additional data from the phase III FRONTIER program in 2025 and 2026.

The possible range of values for the correlation coefficient is -1.0 to 1.0. In other words, the values cannot exceed 1.0 or be less than -1.0.

The change in the density of CD3-positive T cells, or IELs, from baseline was an increase of 13.3 for placebo subjects compared to a decline of 1.5 for FB102 treated subjects (p=0.0035).

As of the data cut-off date of March 21, 2025, 514 patients with ROS1-positive solid tumors had received zidesamtinib at any starting dose across the Phase 1 and Phase 2 portions of the ARROS-1 ...

Phase 2 data highlights best-in-class potential of dual GLP-1R/GIPR agonist BGM0504 for weight management and metabolic risk reduction in individuals with type 2 diabetes and overweight, non-obese ...

Company News Published 06/25/2025, 07:33 AM 0 Biogen reports positive interim data for once-yearly SMA treatment BIIB 3.32% ...